.webp)
The global essential oils and plant extract for livestock market size was estimated at USD 2.90 billion in 2024 and is predicted to increase from USD 3.08 billion in 2025 to approximately USD 5.31 billion by 2034, expanding at a CAGR of 6.24% from 2025 to 2034. The increasing use of essential oil & plant extracts-based feed to enhance the yield is the key factor driving market growth. Also, the rising product demand from the livestock market coupled with the escalating consumption of meat across the globe can drive market growth further.
The global operating room management market size was estimated at USD 3.05 billion in 2024 and is predicted to increase from USD 3.25 billion in 2025 to approximately USD 5.71 billion by 2034, expanding at a CAGR of 6.47% from 2025 to 2034. The demand for efficient resource utilization is the major driver of the global market. The expanding operating room capabilities and rising need for improved communication and collaborative solutions have increased demand for operating room management solutions. Additionally, the growing emphasis on advanced technology implementation with operating room management solutions is generating growth opportunities for the market.
The global RNA editing market size was estimated at USD 15.04 billion in 2024 and is predicted to increase from USD 1.19 billion in 2025 to approximately USD 1.86 billion by 2034, expanding at a CAGR of 15.95% from 2025 to 2034.The demand for RNA editing is increasing due to its increasing use in drug development, which can help develop enhanced therapies.
The global surgical planning software market size was calculated at USD 115.41 million in 2024 and is predicted to increase from USD 123.07 million in 2025 to approximately USD 219.50 million by 2034, expanding at a CAGR of 6.64% from 2025 to 2034. The increased demand for cloud-based platforms is the major driver of the global surgical planning software market. The demand for personalized medicine and minimally invasive surgical procedures has increased; as a result, the adoption of surgical planning software has expanded.
The global healthcare analytical testing services market size was estimated at USD 15.76 billion in 2024 and is predicted to increase from USD 17.09 billion in 2025 to approximately USD 35.47 billion by 2034, expanding at a CAGR of 8.45% from 2025 to 2034. The market is driven by the increase in outsourcing businesses of analytical testing services by pharmaceutical or medical device firms.
The global atherosclerosis drugs market size was estimated at USD 16.98 billion in 2024 and is predicted to increase from USD 17.60 billion in 2025 to approximately USD 24.25 billion by 2034, expanding at a CAGR of 3.63% from 2025 to 2034. The growing prevalence of obesity and diabetes are key drivers of the market. Additionally, the growing prevalence of cardiovascular disease is contributing to the market growth. An aging population is expected to fuel global market growth in the forecast period.
The global cell surface marker detection market size was estimated at USD 5.68 billion in 2024 and is predicted to increase from USD 6.16 billion in 2025 to approximately USD 12.81 billion by 2034, expanding at a CAGR of 8.47% from 2025 to 2034. The global market growth is attributed to the increasing demand for precision medicine.
The global blood cancer diagnostics market size was estimated at USD 10.90 billion in 2024 and is predicted to increase from USD 11.65 billion in 2025 to approximately USD 21.24 billion by 2034, expanding at a CAGR of 6.90% from 2025 to 2034. The increasing incidence of blood cancer, the rising elderly population, growing awareness regarding the early screening of relevant symptoms, and rapid technological advancements in diagnostic techniques are among several factors expected to drive the growth of the global blood cancer diagnostics market throughout the projected period.
The global cell and gene therapy CDMO market size was estimated at USD 6.31 billion in 2024 and is predicted to increase from USD 8.07 billion in 2025 to approximately USD 74.03 billion by 2034, expanding at a CAGR of 27.92% from 2025 to 2034. The rising demand to put specialized expertise, facilities, and regulatory knowledge into developing and manufacturing cell and gene therapy is fueling the CDMO market for cell and gene therapy.
The Europe Pharmaceutical CDMO market size was estimated at USD 42.58 billion in 2024 and is predicted to increase from USD 45.68 billion in 2025 to approximately USD 88.84 billion by 2034, expanding at a CAGR of 7.62% from 2025 to 2034. The market is gaining traction as it allows pharmaceutical companies to have access to specialized expertise, advanced manufacturing facilities, and regulatory compliance support, which are essential components for developing and producing new drugs.
The next generation bioprinting market is experiencing significant growth, driven by advancements in technology, expanding applications, and increasing demand across various end-user industries. The demand for next generation bioprinting is increasing due to the growing focus on drug development that focuses on providing accurate medical testing.
The global pharmaceutical impurity synthesis and isolation services market size accounted for USD 1.25 billion in 2024 and is predicted to increase from USD 1.35 billion in 2025 to approximately USD 2.73 billion by 2034, expanding at a CAGR of 8.12% from 2025 to 2034. The market growth is attributed to increasing pharmaceutical R&D investments and advancements in analytical technologies for impurity detection.
The global advanced therapy medicinal products market size was estimated at USD 35.98 billion in 2024 and is predicted to increase from USD 42.04 billion in 2025 to approximately USD 170.47 billion by 2034, expanding at a CAGR of 16.83% from 2025 to 2034. The market growth is attributed to the increasing demand for personalized and innovative treatments for chronic and rare diseases.
The global electronic skin patches market size was estimated at USD 6.30 billion in 2024 and is predicted to increase from USD 6.96 billion in 2025 to approximately USD 17.10 billion by 2034, expanding at a CAGR of 10.50% from 2025 to 2034. The rising demand for a non-invasive and comfortable approach to monitoring vital signs and other physiological parameters contributes to the growth of the electronic skin patch market.
The global personalized genomics market size accounted for USD 10.73 billion in 2024 and is predicted to increase from USD 12.57 billion in 2025 to approximately USD 12.57 billion by 2034, expanding at a CAGR of 17.73 from 2025 to 2034. The market growth is attributed to the increasing demand for personalized healthcare solutions, driven by advancements in genomic technologies and the rising prevalence of chronic diseases.
The global contract development manufacturing organization outsourcing market size was estimated at USD 171.46 billion in 2024 and is predicted to increase from USD 200.60 billion in 2025 to approximately USD 824.16 billion by 2034, expanding at a CAGR of 17.00% from 2025 to 2034. The demand for contract development and manufacturing organization outsourcing market is attributed to the fact that it allows pharmaceutical companies access to specialized expertise, advanced technologies, and manufacturing capabilities.
The global DNA nanotechnology market size was estimated at USD 5.50 billion in 2024 and is predicted to increase from USD 6.88 billion in 2025 to approximately USD 51.36 billion by 2034, expanding at a CAGR of 25.03% from 2025 to 2034. The market growth is attributed to the rising adoption of DNA nanotechnology in drug delivery and diagnostic applications.
The global spatial genomics and transcriptomics market size was calculated at USD 288.35 million in 2024 and is predicted to increase from USD 323.53 million in 2025 to approximately USD 911.71 million by 2034, expanding at a CAGR of 12.20% from 2025 to 2034. The demand for single-cell analysis has increased, which is responsible for driving the global spatial genomics and transcriptomic market. The introduction of spatial genomics and transcriptomics analysis is drawing a positive impact on market growth. Additionally, the rising government investments and funding for pharmaceutical R&D are making space for market growth.
The global dental sterilization market size was calculated at USD 1.65 billion in 2024 and is predicted to increase from USD 1.80 billion in 2025 to approximately USD 3.84 billion by 2034, expanding at a CAGR of 8.82% from 2025 to 2034. The increasing prevalence of dental issues in the worldwide population and the demand for efficient disinfection of instruments and devices drive the growth of the market.
The global predictive biomarkers market size was estimated at USD 24.31 billion in 2024 and is predicted to increase from USD 28.88 billion in 2025 to approximately USD 136.24 billion by 2034, expanding at a CAGR of 18.81% from 2025 to 2034. The demand for early diagnosis and therapies has increased due to the rising prevalence of chronic disease, making the expansion of the predictive biomarkers market. The market further has witnessed significant growth due to increased demand for personalized medicines. The growing need for non-invasive technologies is projected to drive the market expansions.
The global biotechnology contract manufacturing market size was estimated at USD 21.07 billion in 2024 and is predicted to increase from USD 22.93 billion in 2025 to approximately USD 49.06 billion by 2034, expanding at a CAGR of 8.82% from 2025 to 2034. The demand for biotechnology is increasing due to the rising need for biopharmaceutical products, marking significant growth in product development.
The global next-generation mass spectrometer market size was calculated at USD 2.21 billion in 2024 and is predicted to increase from USD 2.37 billion in 2025 to approximately USD 4.43 billion by 2034, expanding at a CAGR of 7.22% from 2025 to 2034. The next-generation mass spectrometers experience rapid growth due to technological innovation, rising healthcare and pharmaceutical needs, environmental monitoring, government investments, and miniaturization for field applications.
The global collateral ligament stabilizer system market size was calculated at USD 2.24 billion in 2024 and is predicted to increase from USD 2.38 billion in 2025 to approximately USD 4.17 billion by 2034, expanding at a CAGR of 6.41% from 2025 to 2034. The development of the market is driven by factors like increasing sports injuries, demand for minimally invasive treatments, an aging population, technological advancements, and improved healthcare spending.
The global peptide api market size was estimated at USD 59.09 billion in 2024 and is predicted to increase from USD 62.01 billion in 2025 to approximately USD 95.79 billion by 2034, expanding at a CAGR of 4.95% from 2025 to 2034. The demand for Active Pharmaceutical Ingredients (API) is increasing due to the growing preference for targeted therapies marking significant advancements.
The global military and humanitarian trauma care market size was calculated at USD 7.51 billion in 2024 and is predicted to reach around USD 14.40 billion by 2034, expanding at a CAGR of 6.72% from 2025 to 2034. The demand for emergency medical response has increased in military forces; as a result, the military and humanitarian trauma care segment is boosting. The demands for telemedicine and automation in trauma care are driving the military and humanitarian trauma care market. Additionally, rising government spending on military and humanitarian services is projected to boost the market in the forecast period.
The global nocturia market size accounted for USD 4.01 billion in 2024 and is expected to exceed around USD 8.69 billion by 2034, growing at a CAGR of 8.05% from 2025 to 2034. The market growth is attributed to increasing awareness, technological advancements, and a rising demand for effective treatment options for nocturia.
The global melanin market size was calculated at USD 152.08 million in 2024 and is predicted to reach around USD 300.00 million by 2034, expanding at a CAGR of 7.03% from 2025 to 2034. The increasing demand for natural ingredients for UV protection and skin treatment in cosmetics and skin care products drives the growth of the market.
The global diabetic neuropathy market size was calculated at USD 4.50 billion in 2024 and is predicted to reach around USD 9.06 billion by 2034, expanding at a CAGR of 7.24% from 2025 to 2034. The increasing prevalence of diabetic neuropathy in geriatric patients already affected by diabetes and further innovations in the development of novel drugs in the treatment of conditions drive the growth of the market.
The global Cystatin C assay market size was calculated at USD 293.00 million in 2024 and is predicted to reach around USD 616.35 billion by 2034, expanding at a CAGR of 7.72% from 2025 to 2034. The Cystatin C testing market is propelled by the growing prevalence of CKD, improvements in diagnostic technologies, enhanced test accuracy, and greater investments in healthcare.
The global thin film drug manufacturing market size was calculated at USD 7.38 billion in 2024 and is predicted to reach around USD 15.07 billion by 2034, expanding at a CAGR of 7.40% from 2025 to 2034. The demand for convenient and easy-to-use drugs is driving the growth of the global market. The need for fewer side effects and improved adherence to treatment is leveraging the market growth.
The global non-hodgkin's lymphoma therapeutics market size calculated at USD 10.23 billion in 2024 and is predicted to reach around USD 20.94 billion by 2034, expanding at a CAGR of 7.43% from 2025 to 2034. The market is driven by the increasing incidence rate of non-Hodgkin’s Lymphoma, new product development, indication focus on personalized medicine and AI incorporation in diagnosis, governmental encouragement, and enhanced diagnostic tools to investigate early-stage disease.
The global MRI coils market size was calculated at USD 9.58 billion in 2024 and is predicted to reach around USD 22.08 billion by 2034, expanding at a CAGR of 8.71% from 2025 to 2034. Rising demand for diagnostic imaging procedures is the key factor driving market growth. Also, the increasing incidence of chronic disease coupled with technological advancements in imaging techniques can fuel market growth further.
The global single tooth implants and dental bridges market size was calculated at USD 5.83 billion in 2024 and is predicted to reach around USD 9.87 billion by 2034, expanding at a CAGR of 5.10% from 2025 to 2034. The rising demand for single-tooth implants and dental bridges is attributed to the growing need to replace missing teeth and help maintain oral health, including teeth and gyms.
The global retinal vein occlusion market size was calculated at USD 2.82 billion in 2024 and is predicted to reach around USD 5.45 billion by 2034, expanding at a CAGR of 6.81% from 2025 to 2034. The rising awareness about retinal vein occlusion (RVO) and growing regulatory approvals for treatment are the key drivers of the market. Additionally, accessibility audit training for healthcare professionals in rural areas is furthering this awareness in developing regions.
The global albendazole veterinary market size was calculated at USD 203.04 million in 2024 and is predicted to reach around USD 393.48 million by 2034, expanding at a CAGR of 6.84% from 2025 to 2034. The increasing parasitic infection in livestock is attracting the growth of the market. Additionally, various awareness campaigns are contributing to the market expansion.
The global opioid use disorder market size accounted for USD 5.31 billion in 2024 and is expected to exceed around USD 15.32 billion by 2034, growing at a CAGR of 11.18% from 2025 to 2034. The increasing rates of substance use disorders are the key factor driving the market growth. Also, rising government efforts to deal with these disorders, coupled with the increasing awareness of opioid use conditions, can fuel market growth shortly.
The global healthcare electronic data interchange market size accounted for USD 5.34 billion in 2024 and is expected to exceed around USD 13.38 billion by 2034, growing at a CAGR of 9.62% from 2025 to 2034. The expanding legal requirements for the interchange of electronic data drive the healthcare electronic data interchange market.
The global single cell sequencing market size accounted for USD 2.45 billion in 2024 and is expected to exceed around USD 9.91 billion by 2034, growing at a CAGR of 15.00% from 2025 to 2034. Technological advances in the field of genomics are the key factor driving market growth. Also, the increasing incidence of genetic diseases coupled with the collaboration among academic institutions can fuel market growth soon.
The global salt therapy market size accounted for USD 7.87 billion in 2024 and is expected to exceed around USD 19.05 billion by 2034, growing at a CAGR of 9.25% from 2025 to 2034. Increasing awareness about respiratory health is the key factor driving market growth. Also, the surge in wellness tourism coupled with the innovations in equipment and technology can fuel market growth further.
The global peek implants market size was calculated at USD 1.04 billion in 2024 and is predicted to reach around USD 2.23 billion by 2034, expanding at a CAGR of 7.95% from 2025 to 2034. The rising demand for medical materials with higher biocompatibility, great mechanical strength, and corrosion resistance drives the market's growth.
The global lentiviral vector market size accounted for USD 348.61 million in 2024 and is expected to exceed around USD 1,908.19 million by 2034, growing at a CAGR of 18.53% from 2025 to 2034. The market is driven by growth in gene therapy, enhanced research, artificial intelligence integration, FDA approval, and target-specific diseases.
The global health and wellness coaching market size accounted for USD 19.61 billion in 2024 and is expected to exceed USD 37.96 billion by 2034, growing at a CAGR of 7.32% from 2025 to 2034. The growth in the market is due to the growth in awareness, the shift towards preventive healthcare, technology improvements, personalized solutions, and support from government bodies.
The global dental orthotic devices market size accounted for USD 7.22 billion in 2024 and is expected to exceed USD 27.80 billion by 2034, growing at a CAGR of 14.43% from 2025 to 2034. The dental orthotic devices market is driven by increasing dental disorders, technology, awareness, aesthetics, dental treatment involving cosmetics, the aging population, insurance facilities, and personalized treatments.
The global capillary blood collection devices market size accounted for USD 2.19 billion in 2024 and is expected to exceed around USD 3.74 billion by 2034, growing at a CAGR of 5.49% from 2025 to 2034. The capillary blood collection procedures can affect the quality of samples and the accuracy of test results, the capillary blood collection devices market is growing, reflecting the urgent need for testing, and widespread standardization.
The global medical ceramics market size accounted for USD 20.86 billion in 2024 and is expected to exceed around USD 38.07 billion by 2034, growing at a CAGR of 6.21% from 2025 to 2034. The rising demand for medical ceramics is observed due to their unique properties that are suitable for a wide range of medical applications.
The global zirconia based dental materials market size accounted for USD 402.08 million in 2024 and is expected to exceed around USD 902.42 million by 2034, growing at a CAGR of 8.42% from 2025 to 2034. The zirconia based dental materials market growth is attributed to the increasing demand for durable, aesthetically pleasing, and biocompatible dental materials in restorative and cosmetic dentistry.
The global dental implants and prosthetics contract manufacturing market size was calculated at USD 1.43 billion in 2024 and is predicted to reach around USD 3.18 billion by 2034, expanding at a CAGR of 8.31% from 2025 to 2034. The increasing demand for expertise in the manufacturing of dental implants and prosthetics, scalable and cost-effective alternatives to dental device manufacturing, is driving the growth of the dental implants and prosthetics contract manufacturing market.
The global biomedical refrigerators and freezers market size accounted for USD 4.42 billion in 2024 and is expected to exceed around USD 8.23 billion by 2034, growing at a CAGR of 6.41% from 2025 to 2034. The biomedical refrigerators and freezers market is expected to grow due to the increase in the adoption of biopharmaceuticals, the growth of healthcare industries, and the introduction of new technologies.
The global cone beam computed tomography market size was accounted for USD 702.13 million in 2024 and is expected to exceed around USD 1,775.32 million by 2034, growing at a CAGR of 9.72% from 2025 to 2034. The growing demand for cone beam imaging for dental applications is the key factor driving market growth. Also, technological advancements in the field coupled with substantial improvements in healthcare infrastructure can fuel market growth further.
The global dental piezoelectric ultrasonic unit market size was calculated at USD 229.32 million in 2024 and is predicted to reach around USD 381.43 million by 2034, expanding at a CAGR of 5.22% from 2025 to 2034. Increasing dental expenditure is the key factor driving the dental piezoelectric ultrasonic unit market growth. Also, the rising demand for minimally invasive procedures coupled with the surging geriatric population can fuel market growth soon.
